Ingles Markets INC Schedule 13G passive stakes

A Schedule 13G filing reveals that American Century entities and the Stowers Institute for Medical Research collectively hold over 5% of Ingles Markets' Class A Common Stock.

Vanguard Capital Management has reported beneficial ownership of 738,328 shares, representing 5.07% of the outstanding common stock of Ingles Markets Inc.

The Vanguard Group filed an amended Schedule 13G, reporting 0% beneficial ownership of Ingles Markets Inc. common stock following an internal realignment.

Brandes Investment Partners, L.P. has reported a 7.98% beneficial ownership stake in Ingles Markets Inc. common shares.

Brandes Investment Partners, L.P. has filed a Schedule 13G, revealing a beneficial ownership of 5.6% of Ingles Markets Inc.'s Common Shares as of March 31, 2025.

Dimensional Fund Advisors LP has filed an amended Schedule 13G, reporting a 6.8% beneficial ownership stake in Ingles Markets Inc. as of March 31, 2025.

River Road Asset Management, LLC has filed an amended Schedule 13G, revealing a 6.7% beneficial ownership stake in Ingles Markets Inc. as of December 31, 2024.